Nanoparticle albumin-bound paclitaxel in 3 dosing schedules with bevacizumab as first line therapy for HER2-negative metastatic breast cancer: An interim safety analysis Meeting Abstract
| Authors: | Seidman, A. D.; Conlin, A. K.; Moynahan, M. E.; Bach, A.; Troso-Sandoval, T.; Sugarman, S.; Forero, A.; Kerr, R.; Wright, G.; Hudis, C. A. |
| Abstract Title: | Nanoparticle albumin-bound paclitaxel in 3 dosing schedules with bevacizumab as first line therapy for HER2-negative metastatic breast cancer: An interim safety analysis |
| Meeting Title: | 6th European Breast Cancer Conference (EBCC 6) |
| Journal Title: | EJC Supplements |
| Volume: | 6 |
| Issue: | 7 |
| Meeting Dates: | 2008 Apr 15-19 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2008-04-01 |
| Start Page: | 219 |
| Language: | English |
| ACCESSION: | WOS:000256762000591 |
| DOI: | 10.1016/s1359-6349(08)70889-9 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 573 - Poster - 6th European Breast Cancer Conference - APR 15-19, 2008 - Berlin, GERMANY - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
